Bart van Rhijn
Director of Finance/CFO at NANOBIOTIX
Net worth: - $ as of 2024-04-29
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Enno Spillner | M | 55 | 10 years | |
| Laurent Lévy | M | 53 | 21 years | |
| Anne-Marie Graffin | F | 63 | 10 years | |
| Gary Phillips | M | 58 | 3 years | |
| Louis Kayitalire | M | 66 | 1 years | |
| Alain Herrera | M | 74 | 13 years | |
| Patrick Tricoli | M | - | 10 years | |
| Anne-Juliette Hermant | F | 51 | 5 years | |
| Brandon Owens | M | - | - | |
| Margaret Galluzzi | F | - | 5 years | |
| Mariam Hamze | F | 41 |
Galderma International SAS
 Galderma International SAS Pharmaceuticals: MajorHealth Technology Galderma SA develops and markets therapeutic and aesthetic solutions for dermatology. It provides medical dermatological solutions for acne, rosacea, psoriasis and other steroid-responsive dermatoses, onychomycosis, pigmentary disorders, skin cancer and medical aesthetic and corrective solutions for skin senescence. The company was founded in 1981 and is headquartered in Paris, France. | 6 years |
| Craig West | M | - | - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Philippe Mauberna | M | 59 | 8 years | |
| Raffaele Baffa | M | 65 |
Servier Pharmaceuticals LLC
 Servier Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Part of Servier SAS, Servier Pharmaceuticals LLC is a privately held pharmaceutical company focused on oncology. The company is based in Boston, MA. Servier Pharmaceuticals continues to build a treatment portfolio with a current focus on oncology within acute lymphoblastic leukemia. The company invests in innovative research and development through development or partnerships to best address the unmet needs of patients. Additionally, the company is proud to offer financial assistance to not only support patients and their families but a variety of focused advocacy groups and healthcare professionals as well. Servier Pharmaceuticals is committed to engaging with patients, caregivers, families, and patient organizations to ensure their voices are heard in every initiative. The company's responsibility is to help make the world a better place for patients and their families, and it strives to have consistent and concise transparency throughout all clinical trials and research and development for the benefit of all patients. The company was founded in 1954. The CEO is David K. Lee. | 2 years |
| Leonard A. Farber | M | - | 2 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| France | 14 | 93.33% |
| United States | 1 | 6.67% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Bart van Rhijn
- Personal Network